Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
72.0%
% of BBH's 27 holdings also in FBT
60.0%
% of FBT's 31 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 12.6% | 4.2% | 4.2% |
|
AMGEN INC | 18.2% | 4.1% | 4.1% |
|
GILEAD SCIENCES INC | 13.2% | 4.0% | 4.0% |
|
ALNYLAM PHARMACEUTICALS INC | 4.4% | 4.0% | 4.0% |
|
REGENERON PHARMACEUTICALS | 5.9% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to FBT
|
AMGEN INC | 14.1% |
|
GILEAD SCIENCES INC | 9.1% |
|
VERTEX PHARMACEUTICALS INC | 8.4% |
|
IQVIA HOLDINGS INC | 4.2% |
 |
ICON PLC | 3.1% |
|
REGENERON PHARMACEUTICALS | 2.7% |
|
INSMED INC | 2.3% |
 |
ARGENX SE ADR | 2.0% |
|
BIO-TECHNE CORPORATION | 1.7% |
|
CHARLES RIVER LABORATORIES | 1.6% |
BBH Underweight Relative to FBT
|
INTRA-CELLULAR THERAPIES INC | -4.7% |
|
HALOZYME THERAPEUTICS INC | -4.2% |
|
ALKERMES PLC | -4.2% |
|
CORCEPT THERAPEUTICS INC | -4.0% |
|
EXELIXIS INC | -3.5% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.4% |
|
ACADIA PHARMACEUTICALS INC | -3.3% |
|
WATERS CORP | -3.3% |
 |
GENMAB A/S SPONSORED ADR | -3.0% |
|
UNITED THERAPEUTICS CORP | -2.9% |